A

Akari Therapeutics plc

D
AKTX
USD
0.07
(3.0043%)
Market Closed
233.000
Volume
-3.4
EPS
-
Div Yield
-0.803224
P/E
29,147,078.40
Market Cap
Today
3.0043%
1 Week
-3.226%
1 Month
-20.530%
6 Months
61.074%
12 Months
-32.394%
Year To Date
-20.000%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ADMA
0.89
(4.7252%)
USD
A
ACER
(%)
USD
A
ACRX
(%)
USD
A
ARWR
0.055
(0.2579%)
USD
A
AXSM
-0.28
(-0.3079%)
USD
C
CAPR
0.64
(3.5088%)
USD
C
CPRX
0.5
(2.1988%)
USD
A
ARCT
0.38
(2.0663%)
USD
I
IMV
0.01
(1.9608%)
USD

Title:
Akari Therapeutics plc

Sector:
Healthcare
Industry:
Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
Do you need help or have a question?
Contact Us